Prescription drug claim denials by U.S. insurers rose 25% from 2016-2023, according to a new analysis of more than 4B medical ...

Prologis demonstrates robust fundamentals and strong financial flexibility. Read more about PLD stock and what supports a ...

NuScale achieved NRC approval for its 77 MW SMR design, securing a first-mover advantage. Read why SMR stock is still not an ...

ING Groep's main markets are the Netherlands, Germany, and Belgium, with only 5% of loans made in North America. Read why ING ...

Itaú Unibanco stands out as Brazil's top private bank, with superior profitability. Check out what positions ITUB stock for ...

FCPI is overweight in sectors resilient to inflation—consumer staples, healthcare, energy, and basic materials. Read why FCPI ...

Rigetti's stock surged 50% after achieving a key quantum computing milestone. Read why I recommend selling RGTI shares at ...

INFL targets inflation beneficiaries in energy, materials, and financials, aiming for positive real returns in inflationary ...

Read here for an update on a model portfolio that yields 8% and should not only provide sustainable income, but also grow its ...

Artificial Intelligence has indeed been a highly discussed topic and with the recent advancements in areas like generative AI ...

QQQI earns a strong buy rating with its high 13.85% yield, dynamic options strategy, and consistent income. Read more on why ...

Take-Two’s model blends hit-driven development with some recurring revenue. See more on the challenges of investing in video ...